Last reviewed · How we verify

NCT07140653

Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery

Recruiting now Phase 4 Last updated 22 December 2025
What this trial tests

Phase 4 trial testing Femto arcs in Astigmatism in 60 participants. Currently enrolling.

Timeline
2 September 2025
Primary endpoint
2 September 2026
2 September 2026

Quick facts

Lead sponsorCenter For Sight
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment60
Start date2 September 2025
Primary completion2 September 2026
Estimated completion2 September 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Center For Sight — full company profile →

Who can join

21 and older, any sex, with Astigmatism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the safety and effectiveness of femtosecond laser arcuate corneal relaxing incisions (AK) combined with Light Adjustable Lens (LAL) implantation for correcting pre-existing corneal astigmatism in patients undergoing cataract or refractive lens exchange surgery. Postoperative assessments will focus on residual refractive astigmatism, visual outcomes, patient satisfaction, and the incidence of adverse events. Arcuate keratotomy and toric IOLs are well-established methods for astigmatism correction, and this study will compare their combined effectiveness using advanced femtosecond laser technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Astigmatism

Currently open trials in the same condition.

Other Center For Sight trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07140653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing